Abstract
Malaria is caused by members of the genus Plasmodium. The four species infecting humans are Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. Plasmodium sporozoites develop in the salivary glands of female anopheline mosquitoes and are transmitted to humans during a blood meal. The sporozoites remain in the host’s circulation for a brief period before entering hepatocytes, where they develop for 5–16 days depending on the species. During this period they increase in number thousands of times. A uninucleate P. falciparum sporozoite, for example, can develop into a multinucleate liver schizont with as many as 30,000–50,000 uninucleate merozoites. The phase beginning with sporozoite entry into the blood and ending with merozoite invasion of erythrocytes is called the exoerythrocytic phase of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Richards WHR: Active immunization of chicks against Plasmodium gal-linaceum by inactivated homologous sporozoites and erythrocytic parasites. Nature 1966;212:1492–1494.
Nussenzweig RS, Vanderberg J, Most H, Orton C:. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967;216:160–162.
Nussenzweig RS, Vanderberg J, Most H, Orton C:. Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature 1969;222:488–489.
Clyde DF, Most H, McCarthy VC, Vanderberg JP:. Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973; 266:169–177.
Clyde DF, McCarthy VC, Miller RM, Woodward WE:. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975;24:397–401.
Rieckmann KH, Carson PE, Beaudoin RL, et al: Sporozoite induced immunity in man against an ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1974; 68:258–259.
Rieckmann KH, Beaudoin RL, Cassells JS, Sell KW: Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull WHO 1979; 57(suppl): 261–265.
Schofield L, Villaquiran J, Ferreira A, et al:. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987;330:664–666.
Weiss WR, Sedegah M, Beaudoin, RL, et al:. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 1988;85:573–576.
Yoshida N, Nussenzweig RS, Potocnjak P, et al: Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 1980;207:71–73.
Nardin EH, Nussenzweig V, Nussenzweig RS, et al: Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 1982;156:20–30.
Santoro F, Cochrane AH, Nussenzweig V, et al: Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. J Biol Chem 1983;258:3341–3345.
Ellis J, Ozaki LS, Gwadz RW, et al: Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 1983; 302:536–538.
Godson GN, Ellis J, Svec, P, et al: Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature 1983;305:29–33.
Enea V, Arnot D, Schmidt EC, et al: Circumsporozoite gene Plasmodium cynomolgi (Gombak): cDNA cloning and expression of the repetitive circumsporozoite epitope. Proc Natl Acad Sci USA 1984; 81:7520–7524.
Dame JB, Williams JL, McCutchan TF, et al: Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 1984;225:593–599.
Enea V, Ellis J, Zavala F, et al: DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science 1984;225:628–630.
Arnot DE, Barnwell JW, Tam JP, et al: Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science 1985;230:815–818.
McCutchan TF, Lal AA, de la Cruz VF, et al: Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science 1985;230:1381–1383.
Eichinger DJ, Arnot DE, Tam, JP, et al: Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes. Mol Cell Biol 1986;6:3965–3971.
Weber JL, Egan JE, Lyon JA, et al: Plasmodium berghei: cloning of the cir-cumsporozite protein gene. Exp Parasit. 1987; 63:295–300.
Lal AA, de la Cruz VF, Welsh JA, et al: Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. J Biol Chem 1987; 262:2937–2940.
Teisin T, Gross M, Young JF, et al: Cloning and sequencing of the Plasmodium yoelii circumsporozoite gene. Fed Proc 1987;46:2185 (abstract).
Lal AA, de la Cruz VF, Campbell GH, et al: Structure of the circumsporozoite gene of Plasmodium malariae. Mol Biochem Parasit 1988;30: 291–294.
Potocnjak P, Yoshida N, Nussenzweig RS, Nussenzweig V: Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 1980; 151:1504–1513.
Young JF, Hockmeyer WT, Gross M, et al: Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 1985;228:958–962.
Ballou WP, Rothbard J, Wirtz RA, et al: Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. Science 1985;228:996–999.
Weber JL, Hockmeyer WT: Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol Biochem Parasitol 1985;15:305–316.
Zavala F, Tarn JP, Hollingdale MR, et al: Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 1985;228:1436–1440.
Zavala F, Masuda A, Graves PM, et al: Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol 1985;135:2790–2793.
Yoshida N, del Portillo HA, di Santi SM, et al: Plasmodium falciparum: epidemiological studies on the circumsporozoite gene. Exp Parasitol 1987;64:510–513.
Ballou WP, Hoffman SL, Sherwood JA, et al: Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1987;1:1277–1281.
Herrington DA, Clyde DF, Losonsky G, et al: Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 1987;328:257–259.
Hoffman S, Oster CN, Plowe CV, et al: Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 1987;237:639–642.
Egan JE, Weber JL, Ballou WR, et al: Efficacy of murine malaria sporozoite vaccines: Implications for human vaccine development. Science 1987;236:453–456.
Zavala F, Tarn JP, Barr PJ, et al: Synthetic peptide vaccine confers protection against murine malaria. J Exp Med 1987;166:1591–1596.
Beaudoin RL, Strome CPA, Mitchell F, Tubergen TA: Plasmodium berg-hei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp Parasitol 1977;42:1–5.
Charoenvit Y, Leef MF, Yuan LF, et al: Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect, Immun 1987;55:604–608.
Sedegah M, Beaudoin RL, de la Vega P, et al: Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity to Plasmodium yoelii. In Lasky L (ed): 1988 Technological Alzn R. Liss, Inc, New York Advances in Vaccine Development. pp. 295–309.
Charoenvit Y, Mellouk S, Cole C, et al: Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites. J Immunol 1991;146:1020–1025.
Charoenvit Y, Collins WE, Jones TR, et al: Inability of malaria vaccine to induce antibodies to a protective epitope contained within its sequence. Science, 1991;251:668–671.
Geysen HM, Rodda SJ, Mason TJ, et al: Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987,102:259–274.
Collins WE, Nussenzweig RS, Ballou WR, et al: Immunization of Saimiri scireus boliviensis with recombinant vaccines based on circumsporozoite protein of Plasmodium vivax. Am J Trop Med Hyg 1989;40: 455–464.
Rosenberg R, Wirtz RA, Lanar DE, et al: Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science 1989;245:973–976.
Wirtz RA, Rosenberg R, Sattabongkot J, Webster HK: Prevalence of antibody to heterologous circumsporozoite protein of Plasmodium vivax in Thailand. Lancet 1990;336:593–595.
Cochrane AH, Nardin EH, de Arruda M, et al: Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax. Am f Trop Med Hyg 1990;43:446–451.
Rickman LS, Gordon DM, Wistar R, et al: Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet 1991;337:998–1001.
Hoffman SL, Cannon LT, Berzofsky JA, et al: Plasmodium falciparum: sporozoite boosting of immunity due to a T-cell epitope on a sporozoite vaccine. Exp Parasitol 1987;64:64–70.
Morrison SL, Johnson MJ, Herzenberg LA, Oi VT: Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 1984;81:685–6855.
Huse WD, Sastry L, Iverson SA, et al: Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989;246:1275–1281.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Jones, T.R., Ballou, W.R., Hoffman, S.L. (1993). Antibodies to the Circumsporozoite Protein and Protective Immunity to Malaria Sporozoites. In: Sun, T. (eds) Progress in Clinical Parasitology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2732-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2732-8_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7646-3
Online ISBN: 978-1-4612-2732-8
eBook Packages: Springer Book Archive